| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $28.5M | +298.2% |
| R&D Expense | $55.9M | +14.4% |
| SG&A Expense | $18.0M | -21.4% |
| Operating Income | -$45.4M | +29.7% |
| Pre-tax Income | -$39.8M | +34.9% |
| Income Tax | $330K | +900.0% |
| Net Income | -$40.2M | +34.4% |
| EPS (Basic) | -$6.69 | +50.0% |
| EPS (Diluted) | -$6.69 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $38.3M | +93.3% |
| Accounts Receivable | $0 | -100.0% |
| Current Assets | $115.5M | -13.7% |
| Total Assets | $119.2M | -12.9% |
| Current Liabilities | $47.8M | +21.9% |
| Total Liabilities | $85.8M | -10.4% |
| Stockholders' Equity | $33.4M | -18.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$51.1M | -324.8% |
| Capital Expenditures | $28K | -89.0% |
| Investing Cash Flow | $40.2M | +158.1% |
| Financing Cash Flow | $29.4M | +113.1% |
| Free Cash Flow | -$51.1M | -327.4% |
| +50.0% |